Unison Advisors LLC United Therapeutics Corp Transaction History

Unison Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$203.3 - $244.17 $107,749 - $129,410	530 Added 30.23%	2,283 $478,000
Q4 2020 Jan 19, 2021	BUY	$101.87 - $151.79 $178,578 - $266,087	1,753 New	1,753 $266,000
Q3 2020 Oct 27, 2020	SELL	$99.9 - $121.13 $175,124 - $212,340	-1,753 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$92.74 - $125.82 $162,573 - $220,562	1,753 New	1,753 $212,000
Q2 2019 Jul 11, 2019	SELL	$76.06 - $120.81 $133,333 - $211,779	-1,753 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$107.15 - $126.84 $187,833 - $222,350	1,753 New	1,753 $205,000
Q4 2018 Feb 05, 2019	SELL	$101.4 - $128.73 $177,754 - $225,663	-1,753 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$113.81 - $129.46 $199,508 - $226,943	1,753 New	1,753 $224,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $187,939 - $266,350	-1,753 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$118.58 - $151.28 $207,870 - $265,193	1,753	1,753 $259,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Unison Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Unison Advisors LLC with notifications on news.